Anemia of Chronic Disease with Functional Iron Deficiency and Folate Deficiency
This patient has anemia of chronic disease (ACD) with functional iron deficiency (FID) and concurrent folate deficiency, driven by marked inflammation (CRP 124 mg/L). The primary management should address the underlying inflammatory condition while supplementing folate and considering iron therapy.
Diagnosis
The laboratory pattern is classic for ACD with FID:
- Markedly elevated CRP (124 mg/L) indicates severe active inflammation 1
- Low serum iron (34 µg/dL), low TIBC (224 µg/dL), and low transferrin saturation (15%) reflect inflammation-induced hepcidin upregulation, which traps iron in macrophages and prevents its delivery to erythroblasts 1
- Normal ferritin (125 ng/mL) appears adequate but is misleading—ferritin is an acute phase reactant that rises with inflammation. In the presence of inflammation, ferritin up to 100 µg/L may still indicate iron deficiency, and ferritin 100-300 ng/mL with transferrin saturation <20% suggests functional iron deficiency 1
- Low folate (2.6 ng/mL) represents true deficiency requiring supplementation 2
- Normal B12 (629 pg/mL) excludes B12 deficiency as a contributor
The low TIBC is particularly important—it distinguishes ACD from pure iron deficiency anemia, where TIBC would be elevated 3, 4. This patient's iron is sequestered in reticuloendothelial stores but unavailable for erythropoiesis due to inflammatory cytokines 1, 4.
Management Algorithm
1. Identify and Treat the Underlying Inflammatory Condition
This is the most critical step. With CRP at 124 mg/L (normal <5 mg/L), investigate for:
- Inflammatory bowel disease
- Chronic infection
- Malignancy
- Autoimmune disorders
- Chronic kidney disease 3, 5
The anemia will not fully resolve until inflammation is controlled 1, 4.
2. Supplement Folate Immediately
Start oral folic acid 1-5 mg daily. Folate deficiency contributes to macrocytic changes and impaired erythropoiesis 2. This is straightforward and should begin immediately.
3. Iron Supplementation Decision
Iron supplementation is recommended despite the normal ferritin 1. The diagnostic criteria for FID in the presence of inflammation are met: ferritin 100-300 ng/mL with transferrin saturation <20% 1.
- Intravenous iron is preferred over oral iron in inflammatory conditions because oral absorption is impaired by hepcidin 1, 5
- Target: increase hemoglobin by at least 2 g/dL within 4 weeks 1
- Oral iron may exacerbate inflammation in certain conditions (particularly inflammatory bowel disease) and is poorly absorbed 1
4. Monitor Response
Recheck complete blood count, iron studies, and CRP in 4 weeks:
- Expect hemoglobin rise of ≥2 g/dL if treatment is effective 1
- Reticulocyte count should increase, indicating bone marrow response 3
- If no response, consider erythropoiesis-stimulating agents if underlying condition is chronic kidney disease or other appropriate indication 3, 4
Key Pitfalls to Avoid
Do not be falsely reassured by the normal ferritin. In inflammation, ferritin levels are elevated as an acute phase reactant, masking true iron deficiency 1, 6. A ferritin of 125 ng/mL with transferrin saturation of 15% in the setting of CRP 124 mg/L indicates functional iron deficiency.
Do not use oral iron as first-line therapy in severe inflammation. Hepcidin blocks duodenal iron absorption, rendering oral supplementation ineffective 1, 5.
Do not delay folate supplementation. This is a clear deficiency that requires immediate correction 2.
Do not forget to investigate the cause of severe inflammation. CRP of 124 mg/L demands thorough evaluation for underlying disease 1, 5.
The combination of low TIBC, low transferrin saturation, and normal-appearing ferritin in the context of marked inflammation is pathognomonic for ACD with FID 1, 4. Treatment success depends primarily on controlling the underlying inflammatory process while providing appropriate nutritional supplementation 1, 4, 5.